A new publication involving humanin appeared on September 10, 2026. The study, titled "Humanin Attenuates Inflammatory Liver Injury and NF-κB Activation During Systemic Hypervirulent Klebsiella pneumoniae Infection," was published in the journal Pathogens (Basel, Switzerland).
The publication is indexed under PubMed ID 42796734. Humanin remains classified as an unapproved research compound, and this entry reflects only the existence and title of the new publication.
No findings, outcomes, or data from the study are detailed here beyond the title and journal of publication. Readers interested in the full scope of the research are encouraged to consult the original source directly for complete details.
For additional background on humanin, readers can refer to the compound overview page.